Clinical history | All (N = 33) | Male (N = 24) | Female (N = 9) | P-value |
---|---|---|---|---|
Age (years) | 63 ± 13 | 62.6 ± 12 | 64 ± 15 | 0.78 |
Current smoker (no. [%]) | 9 (27%) | 8 (33%) | 1 (11%) | 0.21 |
Hypertension (no. [%]) | 9 (27%) | 7 (29%) | 2 (22%) | 0.70 |
Diabetes Mellitus (no. [%]) | 10 (30%) | 6 (25%) | 4 (44%) | 0.29 |
Dyslipidaemia (no. [%]) | 7 (21%) | 6 (25%) | 1 (11%) | 0.40 |
Myocardial Infarction (no. [%]) | 12 (36%) | 11 (46%) | 1 (11%) | 0.07 |
CABG (no. [%]) | 4 (12%) | 3 (13%) | 1 (11%) | 0.92 |
Abnormal ECG (no. [%]) | 7 (21%) | 5 (21%) | 2 (22%) | 0.93 |
CMR characteristics | ||||
Presence of Infarction (no. [%]) | 19 (58%) | 16 (67%) | 3 (33%) | 0.09 |
Perfusion Defect (no. [%]) | 14 (42%) | 12 (50%) | 2 (22%) | 0.16 |
LV EDV, (ml/m2) | 137 ± 41 | 150.9 ± 37 | 101.2 ± 25 | < 0.0001 |
LV ESV, (ml/m2) | 53 ± 32 | 31.8 ± 9 | 61.2 ± 33 | 0.01 |
LV SV, (ml/m2) | 82 ± 27 | 86.3 ± 29 | 69.3 ± 19 | 0.11 |
LV EF, (%) | 63 ± 13 | 68.2 ± 5 | 61.7 ± 15 | 0.22 |
LV Mass (grams) | 109 ± 36 | 120.7 ± 33 | 76.9 ± 20 | < 0.0001 |
GLS (%) | -19 ± 4 | -17.4 ± 4 | -21.6 ± 3 | < 0.0001 |
E’ (s − 1) | 81 ± 40 | 69.5 ± 22 | 112.3 ± 61 | < 0.0001 |
A’ (s − 1) | 82 ± 30 | 77.1 ± 30 | 95.9 ± 25 | 0.11 |
LAC (ml) | 10.5 ± 15 | 11.2 ± 16 | 8.8 ± 10 | 0.69 |